HMN-709, a chlorobenzenesulfonamide derivative, is a new membrane-permeable calmodulin antagonist

Japanese Journal of Pharmacology

Volumn 72, Issue 2, 1996, Pages 127-135

  Yokokura, Hisayuki ^a   Okada, Yohei ^a   Terada, Osamu ^a   Hidaka, Hiroyoshi ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Affinity chromatography; Calmodulin; Calmodulin antagonist; IC50; Platelet function

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; CALMODULIN; CALMODULIN INHIBITOR; CHLOROBENZENE; CYCLIC AMP DEPENDENT PROTEIN KINASE; HMN 709; MYOSIN LIGHT CHAIN KINASE; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; PHORBOL DIBUTYRATE; PHOSPHODIESTERASE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; SEROTONIN; SULFONAMIDE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NORMAL HUMAN; SEROTONIN RELEASE; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0029797161     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.72.127     Document Type: Article

References (47)

1. Cheung WY: Cyclic 3′,5′-nucleotide phosphodiesterase: demonstration of an activator. Biochem Biophys Res Commun 38, 533-538 (1970)
2. Nairn AC and Picciotto MR: Calcium/calmodulin-dependent protein kinases. Semin Cancer Biol 5, 295-303 (1994)
3. Klee CB, Draetta GF and Hubbard MJ: Calcineurin. Adv Enzymolol, 149-200 (1988)
4. 2+-dependent regulation of the spectrin/actin interaction by calmodulin and protein 4.1. J Biol Chem 266, 1134-1140 (1991)
5. Cohen P and Klee CB: Calmodulin. Elsevier Science Publishing Company Inc, New York (1988)
6. Lu KP and Means AR: Regulation of the cell cycle by calcium and calmodulin. Endocrinol Rev 14, 40-58 (1993)
7. Wolff DJ and Brostrom CO: Properties and functions of the calcium-dependent regulator protein. In Advances in Cyclic Nucleotide Research, Edited by Greengard P and Robison GA, Vol 11, pp 27-88, Raven Press, New York (1979)
8. Tanaka T and Hidaka H: Hydrophobic regions function in calmodulin-enzyme(s) interactions. J Biol Chem 255, 11078-11080 (1980)
9. Ikura M, Clore GM, Gronenborn AM, Zhu G, Klee CB and Bax A: Solution structure of a calmodulin-target peptide complex by multidimensional NMR. Science 256, 632-638 (1992)
10. Levin RM and Weiss B: Binding of trifluoperazine to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. Mol Pharmacol 13, 690-697 (1977)
11. 2+-dependent protein kinase inhibition by R-24571, a calmodulin antagonist. Biochem Pharmacol 33, 125-130 (1984)
12. Nakajima T and Katoh A: Selective calmodulin inhibition toward myosin light chain kinase by a new cerebral circulation improver, Ro 22-4839. Mol Pharmacol 32, 140-146 (1987)
13. 2+-dependent binding of tamoxifen to calmodulin isolated from bovine brain. Cancer Res 50, 2753-2758 (1990)
14. Hidaka H, Asano M, Iwadare S, Matsumoto I, Totsuka T and Aoki N: A novel vascular relaxing agent, N(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide which affects vascular smooth muscle actomyosin. J Pharmacol Exp Ther 207, 8-15 (1978)
15. Cook WJ, Walter LJ and Walter MR: Drug binding by calmodulin: crystal structure of a calmodulin-trifluoperazine complex. Biochemistry 33, 15259-15265 (1994)
16. 2+-calmodulin dependent phosphorylation and platelet secretion. Nature 287, 863-865 (1980)
17. Hidaka H, Yamaki T, Naka M, Tanaka T, Hayashi H and Kobayashi R: Calcium-regulated modulator protein interacting agents inhibit smooth muscle calcium-stimulated protein kinase and ATPase. Mol Pharmacol 17, 66-72 (1980)
18. Hidaka H, Sasaki Y, Tanaka T, Endo T, Ohno S, Fujii Y and Nagata T: N-(6-Aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. Proc Natl Acad Sci USA 78, 4354-4357 (1981)
19. Naccache PH, Molski TFP, Alobaidi T, Backer EL, Showell HJ and Sha'afi RI: Calmodulin inhibitors block neutrophil degranulation at a step distal from the mobilization of calcium. Biochem Biophys Res Commun 97, 62-68 (1980)
20. Hidaka H, Inagaki M, Kawamoto S and Sasaki Y: Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23, 5036-5041 (1984)
21. Hashimoto Y and Soderling TR: Calcium/calmodulin-dependent protein kinase 11 and calcium/phospholipid-dependent protein kinase activities in rat tissues assayed with a synthetic peptide. Arch Biochem Biophys 252, 418-425 (1987)
22. Kemp BE, Pearson RB, Guerriero V Jr, Bagchi IC and Means AR: The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence. J Biol Chem 262, 2542-2548 (1987)
23. Yazawa M, Sakuma M and Yagi K: Calmodulins from muscles of marine invertebrates, scallop and sea anemone. J Biochem (Tokyo) 87, 1313-1320 (1980)
24. Yokokura H, Picciotto MR, Nairn AC and Hidaka H: The regulatory region of calcium/calmodulin-dependent protein kinase I contains closely associated autoinhibitory and calmodulin-binding domains. J Biol Chem 270, 23851-23859 (1995)
25. Adelstein RS and Klee CB: Purification and characterization of smooth muscle myosin light chain kinase. J Biol Chem 256, 7501-7509 (1981)
26. Beavo JA, Bechtel PL and Krebs EG: Preparation of homogenous cyclic AMP-dependent protein kinase(s) and its subunits from rabbit skeletal muscle. Methods Enzymol 38, 299-308 (1974)
27. Roskoski R Jr: Assays of protein kinase. Methods Enzymol 99, 3-6 (1983)
28. Chijiwa T, Mishima A, Hagiwara M, Sano M, Hayashi T, Inoue T, Naito K, Toshioka T and Hidaka H: Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J Biol Chem 265, 5267-5272 (1990)
29. Inagaki M, Yokokura H, Itoh T, Kanmura Y, Kuriyama H and Hidaka H: Purified rabbit brain protein kinase C relaxes skinned vascular smooth muscle and phosphorylates myosin light chain. Arch Biochem Biophys 254, 136-141 (1987)
30. Hidaka H and Asano T: Platelet cyclic 3′,5′-nucleotide phosphodiesterase related by thrombin and calcium ionophore. J Biol Chem 251, 7508-7518 (1976)
31. Schmidt KG and Rasmussen JW: Preparation of platelet suspensions from whole blood in buffer. Description of a method which gives a large platelet yield. Scand J Haematol 23, 88-96 (1979)
32. Costa JL and Murphy DL: Platelet 5-HT uptake and release stopped rapidly by formaldehyde. Nature 255, 407-408 (1975)
33. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277, 680-685 (1970)
34. Bradford M: A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254 (1976)
35. Sasaki T, Naka M, Nakamura F and Tanaka T: Ruthenium red inhibits the binding of calcium to calmodulin required for enzyme activation. J Biol Chem 30, 21518-21523 (1992)
36. MacNeil S, Griffin M, Cook AM, Pettett NJ, Dawson RA, Owen R and Blackburn GM: Calmodulin antagonists of improved potency and specificity for use in the study of calmodulin biochemistry. Biochem Pharmacol 37, 1717-1723 (1988)
37. Davis JRE, Hoggard N, Wilson EM, Vidal ME and Sheppard MC: Calcium/calmodulin regulation of the rat prolactin gene is conferred by the proximal enhancer region. Mol Endocrinol 5, 8-12 (1991)
38. Asano M and Hidaka H: Biopharmacological properties of naphthalenesulfonamides as potent calmodulin antagonists. In Calcium and Cell Function, Edited by Cheung WY, Vol 5, pp 123-164, Academic Press, New York (1984)
39. Daniel JL, Holmsen H and Adelstein RS: Thrombin-stimulated myosin phosphorylation in intact platelets and its possible involvement secretion. Thromb Haemostas 38, 984-989 (1977)
40. Adelstein RS and Conti MA: Phosphorylation of platelet myosin increases actin-activated myosin ATPase activity. Nature 256, 597-598 (1975)
41. Lebowitz EA and Cooke RJ: Contractile Properties of actomyosin from human blood platelets. J Biol Chem 253, 5443-5447 (1978)
42. Hathaway DR and Adelstein RS: Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity. Proc Natl Acad Sci USA 76, 1653-1657 (1979)
43. Saito M, Naka M and Hidaka H: The modulatory role of myosin light chain phosphorylation in human platelet activation. Biochem Biophys Res Commun 140, 280-287 (1986)
44. Kawamoto S and Hidaka H: 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets. Biochem Biophys Res Commun 125, 258-264 (1984)
45. 2+-activated, phospholipid-dependent myosin phosphorylation. J Biol Chem 259, 14321-14323 (1984)
46. 2+-dependent protein kinase from heart. J Biol Chem 257, 8489-8495 (1982)
47. 2+ Receptors, Edited by Kakiuchi S, Hidaka H and Means AR, pp19-33, Plenum Press, New York (1982)